Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
Apex Fusion Announces Launch of PRIME Chain and AP3X Token
The launch of the AP3X token and PRIME Chain advance Apex Fusion’s goal of unifying blockchain ecosystems and enabling web3 networks to work in harmony. This will accelerate the creation of powerful ...
Royal Caribbean announces name, Florida home for 3rd Icon-class ship
Royal Caribbean announced the name and home port for its third Icon-class ship that is set to inherit the title of world’s ...